Evaluating a physical activity program for breast and colon cancer survivors
Evaluating a Physical Activity Index for Assessment and Counseling for Breast and Colon Cancer Survivors in Clinical Practice
This study is testing a new exercise program to see if it can help breast and colon cancer survivors be more active and stick with their fitness goals.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 22 (estimated) |
| Ages | 50 Years and up |
| Sex | All |
| Sponsor | Wake Forest University Health Sciences Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Winston-Salem, North Carolina) |
| Trial ID | NCT06340503 on ClinicalTrials.gov |
What this trial studies
This research focuses on assessing the effectiveness of a physical activity index screener combined with exercise coaching and self-monitoring tools to enhance physical activity levels among survivors of breast and colon cancer. The study aims to determine feasibility metrics such as participation rates, adherence, and retention in the program. Participants will utilize research-grade accelerometers and activity trackers to monitor their progress, alongside receiving educational materials and consultation calls to support their exercise journey.
Who should consider this trial
Good fit: Ideal candidates are survivors of breast or colon cancer, aged 50 or older, who completed their primary treatment at least three months prior to enrollment.
Not a fit: Patients with metastatic disease, recurrence of cancer, or those with prior conditions contraindicating exercise may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve physical activity levels and overall health outcomes for breast and colon cancer survivors.
How similar studies have performed: Other studies have shown positive outcomes with similar physical activity interventions for cancer survivors, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Survivors of breast or colon cancer (stages 0-III) diagnosed within the last three years prior to enrollment. * Completed primary treatment (surgery, chemotherapy, and/or radiation) at least 3 months prior to enrollment. * At least 50 years of age or older. * Access to internet or cellular plan for video calls. * Being willing and able to comply with the approved protocol and able to sign an IRB-approved informed consent document directly, remotely or via electronic consent. * Able to read and speak English Exclusion Criteria: * Participants with metastatic disease. * Participants with recurrence or diagnosis of a different cancer. * Participants receiving treatment other than maintenance therapy for their primary cancer (breast or colon). * Participants has prior conditions that contraindicate exercise as determined by treating physician. * Participants has gross cognitive impairment as determined by treating physician.
Where this trial is running
Winston-Salem, North Carolina
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center — Winston-Salem, North Carolina, United States (Recruiting)
Study contacts
- Principal investigator: Shirley Bluethmann — Wake Forest Baptist Comprehensive Cancer Center
- Study coordinator: Study Coordinator
- Email: chcrotts@wakehealth.edu
- Phone: 336-713-8503
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.